These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16557102

  • 21. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 22. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A.
    Am J Nephrol; 2008 Jan; 28(1):115-21. PubMed ID: 17943020
    [Abstract] [Full Text] [Related]

  • 23. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
    Tarng DC, Hung SC, Huang TP.
    J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
    [Abstract] [Full Text] [Related]

  • 24. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
    Easom A.
    Nephrol Nurs J; 2006 Sep; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
    [Abstract] [Full Text] [Related]

  • 25. Importance of ferritin for optimizing anemia therapy in chronic kidney disease.
    Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y.
    Am J Nephrol; 2010 Sep; 32(5):439-46. PubMed ID: 20881381
    [Abstract] [Full Text] [Related]

  • 26. Evaluating iron status in hemodialysis patients.
    Enders HM.
    Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370
    [Abstract] [Full Text] [Related]

  • 27. Serum ferritin and tissue iron in anemic dialysis patients.
    Bárány P, Eriksson LC, Hultcrantz R, Pettersson E, Bergström J.
    Miner Electrolyte Metab; 1997 Aug; 23(3-6):273-6. PubMed ID: 9387132
    [Abstract] [Full Text] [Related]

  • 28. Erythropoietin and iron.
    Sunder-Plassmann G, Hörl WH.
    Clin Nephrol; 1997 Mar; 47(3):141-57. PubMed ID: 9105761
    [Abstract] [Full Text] [Related]

  • 29. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A, Dalton CL.
    Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
    [Abstract] [Full Text] [Related]

  • 30. Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin?
    Milman N, Byg KE, Bergholt T, Eriksen L, Hvas AM.
    Ann Hematol; 2006 Sep; 85(9):567-73. PubMed ID: 16733739
    [Abstract] [Full Text] [Related]

  • 31. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
    Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M.
    Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
    [Abstract] [Full Text] [Related]

  • 32. Diagnosis of iron deficiency in patients undergoing hemodialysis.
    Buttarello M, Pajola R, Novello E, Rebeschini M, Cantaro S, Oliosi F, Naso A, Plebani M.
    Am J Clin Pathol; 2010 Jun; 133(6):949-54. PubMed ID: 20472854
    [Abstract] [Full Text] [Related]

  • 33. The prevalence of iron deficiency among patients presenting with colorectal cancer.
    Beale AL, Penney MD, Allison MC.
    Colorectal Dis; 2005 Jul; 7(4):398-402. PubMed ID: 15932566
    [Abstract] [Full Text] [Related]

  • 34. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 35. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study.
    Krafft A, Perewusnyk G, Hänseler E, Quack K, Huch R, Breymann C.
    BJOG; 2005 Apr; 112(4):445-50. PubMed ID: 15777442
    [Abstract] [Full Text] [Related]

  • 36. The relationship between iron stores and corrected QT dispersion in patients undergoing hemodialysis.
    Dervişoğlu E, Yilmaz A, Sevin E, Kalender B.
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):270-4. PubMed ID: 17785215
    [Abstract] [Full Text] [Related]

  • 37. [Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients].
    López T, Almirall J, Calvet X, Quesada M, Sanfeliú I, Segura F, García M.
    Nefrologia; 2006 Sep; 26(6):673-8. PubMed ID: 17227244
    [Abstract] [Full Text] [Related]

  • 38. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E, Pereira BJ, Rocha-Pereira P, Rocha S, Reis F, Castro E, Teixeira F, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Am J Nephrol; 2008 Sep; 28(4):677-83. PubMed ID: 18354252
    [Abstract] [Full Text] [Related]

  • 39. Acute- phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania.
    Friis H, Range N, Braendgaard Kristensen C, Kaestel P, Changalucha J, Malenganisho W, Krarup H, Magnussen P, Bengaard Andersen A.
    Br J Nutr; 2009 Jul; 102(2):310-7. PubMed ID: 19175946
    [Abstract] [Full Text] [Related]

  • 40. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?
    Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH.
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S9-18. PubMed ID: 17699375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.